Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm®
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

THERAPY FROM A CRITICAL VIEWPOINT
Discontinue beta-blockers after myocardial infarction without cardiac failure?

NEW ON THE MARKET
High-dose aflibercept (EYLEA) for macular degeneration/diabetic macular edema

a-t READERS QUESTIONS AND COMMENTS
Recommendation of the German Standing Committee on Vaccination (STIKO): meningococcal B vaccine (BEXSERO) for infants

IN BRIEF
Stress ulcer prophylaxis during ventilation: less bleeding, but no effect on mortality
Unexpected pregnancies with semaglutide (OZEMPIC, WEGOVY) and tirzepatide (MOUNJARO)
Early detection of familial hypercholesterinaemia: IQWiG favours cascade screening
Intravenous iron: clarification by the company Vifor on FERINJECT and the competitor product MONOFER
Multivitamins without effect on mortality
Gender marketing: BUSCOPAN PLUS in pink  free article 

SIDE EFFECTS
Liver damage with fezolinetant (VEOZA)

e a-t ON THE INTERNET
Patent thickets for original preparations hinder the market introduction of generics
© 2024 arznei-telegramm